BPMC
Price
$128.20
Change
-$0.14 (-0.11%)
Updated
Jul 2 closing price
Capitalization
8.28B
27 days until earnings call
OXBDF
Price
$4.23
Change
-$0.05 (-1.17%)
Updated
Jul 1 closing price
Capitalization
460.84M
Interact to see
Advertisement

BPMC vs OXBDF

Header iconBPMC vs OXBDF Comparison
Open Charts BPMC vs OXBDFBanner chart's image
Blueprint Medicines
Price$128.20
Change-$0.14 (-0.11%)
Volume$2.32M
Capitalization8.28B
Oxford Biomedica
Price$4.23
Change-$0.05 (-1.17%)
Volume$100
Capitalization460.84M
BPMC vs OXBDF Comparison Chart in %
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. OXBDF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and OXBDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (BPMC: $128.21 vs. OXBDF: $4.23)
Brand notoriety: BPMC and OXBDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 59% vs. OXBDF: 1%
Market capitalization -- BPMC: $8.28B vs. OXBDF: $460.84M
BPMC [@Biotechnology] is valued at $8.28B. OXBDF’s [@Biotechnology] market capitalization is $460.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileOXBDF’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • OXBDF’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMC is a better buy in the long-term than OXBDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 4 TA indicator(s) are bullish while OXBDF’s TA Score has 4 bullish TA indicator(s).

  • BPMC’s TA Score: 4 bullish, 5 bearish.
  • OXBDF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, OXBDF is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а -0.03% price change this week, while OXBDF (@Biotechnology) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.28B) has a higher market cap than OXBDF($461M). BPMC YTD gains are higher at: 46.996 vs. OXBDF (-21.594).
BPMCOXBDFBPMC / OXBDF
Capitalization8.28B461M1,796%
EBITDA-66.42MN/A-
Gain YTD46.996-21.594-218%
P/E RatioN/AN/A-
Revenue562MN/A-
Total Cash576MN/A-
Total Debt467MN/A-
FUNDAMENTALS RATINGS
BPMC vs OXBDF: Fundamental Ratings
BPMC
OXBDF
OUTLOOK RATING
1..100
1894
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
53100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
3760
P/E GROWTH RATING
1..100
6698
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OXBDF's Valuation (70) in the null industry is in the same range as BPMC (81) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (53) in the Biotechnology industry is somewhat better than the same rating for OXBDF (100) in the null industry. This means that BPMC’s stock grew somewhat faster than OXBDF’s over the last 12 months.

OXBDF's SMR Rating (93) in the null industry is in the same range as BPMC (96) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Price Growth Rating (37) in the Biotechnology industry is in the same range as OXBDF (60) in the null industry. This means that BPMC’s stock grew similarly to OXBDF’s over the last 12 months.

BPMC's P/E Growth Rating (66) in the Biotechnology industry is in the same range as OXBDF (98) in the null industry. This means that BPMC’s stock grew similarly to OXBDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCOXBDF
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTSCX31.420.39
+1.26%
Russell Inv Tax-Managed US Mid&Sm Cap C
RPEAX40.800.36
+0.89%
Davis Opportunity A
MRERX51.21N/A
N/A
MFS Core Equity R2
JSPJX21.43N/A
N/A
Jackson Square Large-Cap Growth Inv
INSAX23.42N/A
N/A
Catalyst Insider Buying A

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
-1.08%
IMMP - OXBDF
23%
Poorly correlated
+0.61%
BPMC - OXBDF
21%
Poorly correlated
+0.12%
BDTX - OXBDF
21%
Poorly correlated
N/A
ATNM - OXBDF
21%
Poorly correlated
-3.57%
UBX - OXBDF
20%
Poorly correlated
-10.67%
More